IL18 and immune system disorder: Both endogenous and exogenous IL-37 have been shown to ameliorate inflammation and regulate immune disorder via inhibiting the production of inflammatory mediators including IFN-γ, TNF-α, IL-6, and IL-18 [6, 7].